{"status": "OK", "response": {"docs": [{"type_of_material": "Editorial", "blog": [], "news_desk": null, "lead_paragraph": "What will medicine be able to do 20 years from now? Last week Dr. Luther L. Terry, who is Surgeon General of the United States Public Health Service, and thus in a sense is family doctor to the nation, predicted dramatic achievements.", "headline": {"main": "Forecast"}, "abstract": null, "print_page": "E6", "word_count": 1331, "_id": "4fc428ea45c1498b0d95963f", "snippet": "What will medicine be able to do 20 years from now? Last week Dr. Luther L. Terry, who is Surgeon General of the United States Public Health Service, and thus in a sense is family doctor to the nation, predicted dramatic achievements.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/abstract.html?res=9A02E4DB1E38E13ABC4C52DFB466838E679EDE", "multimedia": [], "subsection_name": null, "keywords": [{"name": "glocations", "value": "UNITED STATES"}, {"name": "subject", "value": "RABIES"}, {"name": "subject", "value": "MEASLES"}, {"name": "subject", "value": "MEDICINE AND HEALTH"}, {"name": "subject", "value": "MISCELLANEOUS SECTION"}], "byline": {"person": [{"organization": "", "role": "reported", "firstname": "Walter", "rank": 1, "lastname": "SULLIVANW"}], "original": "By WALTER SULLIVANW.S"}, "document_type": "article", "pub_date": "1965-02-14T00:00:00Z", "section_name": null}, {"type_of_material": "Article", "blog": [], "news_desk": null, "lead_paragraph": "Penicillin has by no means lost its standing as a wonder drug. But currently it has some of the nation's leading drug manufacturers wondering just how to handle it.", "headline": {"main": "Drug Men Studying How to Implement New Penicillin Rule; Drug Makers Studying Ways to Implement New Regulations"}, "abstract": "mfrs study implementation of rule on prevention of inadvertent contamination of other drugs by penicillin", "print_page": "F1", "word_count": 798, "_id": "4fc4212a45c1498b0d9348cc", "snippet": "Penicillin has by no means lost its standing as a wonder drug. But currently it has some of the nation's leading drug manufacturers wondering just how to handle it.", "source": "The New York Times", "slideshow_credits": null, "web_url": "http://query.nytimes.com/gst/abstract.html?res=980DE5DB1E38E13ABC4C52DFB466838E679EDE", "multimedia": [], "subsection_name": null, "keywords": [{"name": "subject", "value": "PENICILLIN"}, {"name": "subject", "value": "DRUGS AND DRUG TRADE"}], "byline": {"person": [{"firstname": "Douglas", "middlename": "W.", "lastname": "CRAY", "rank": 1, "role": "reported", "organization": ""}], "original": "By DOUGLAS W. CRAY"}, "document_type": "article", "pub_date": "1965-02-14T00:00:00Z", "section_name": null}], "meta": {"hits": 2, "offset": 0, "time": 54}}, "copyright": "Copyright (c) 2013 The New York Times Company.  All Rights Reserved."}